STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 55 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $346,000 | -98.3% | 71,500 | -96.2% | 0.00% | -100.0% |
Q4 2019 | $20,022,000 | +19.5% | 1,883,518 | +17.1% | 0.01% | +10.0% |
Q3 2019 | $16,751,000 | +2396.4% | 1,609,085 | +3573.7% | 0.01% | – |
Q2 2019 | $671,000 | +19.2% | 43,800 | 0.0% | 0.00% | – |
Q1 2019 | $563,000 | +62.2% | 43,800 | +20.0% | 0.00% | – |
Q4 2018 | $347,000 | -30.3% | 36,500 | +21.7% | 0.00% | – |
Q3 2018 | $498,000 | +9.0% | 30,000 | +5.3% | 0.00% | – |
Q2 2018 | $457,000 | +26.9% | 28,500 | +21.3% | 0.00% | – |
Q1 2018 | $360,000 | +19.6% | 23,500 | +21.8% | 0.00% | – |
Q4 2017 | $301,000 | +40.7% | 19,300 | 0.0% | 0.00% | – |
Q3 2017 | $214,000 | +20.2% | 19,300 | 0.0% | 0.00% | – |
Q2 2017 | $178,000 | +836.8% | 19,300 | +1384.6% | 0.00% | – |
Q1 2015 | $19,000 | -13.6% | 1,300 | 0.0% | 0.00% | – |
Q4 2014 | $22,000 | +37.5% | 1,300 | 0.0% | 0.00% | – |
Q3 2014 | $16,000 | -57.9% | 1,300 | -50.0% | 0.00% | – |
Q2 2014 | $38,000 | +660.0% | 2,600 | +983.3% | 0.00% | – |
Q1 2014 | $5,000 | – | 240 | +1163.2% | 0.00% | – |
Q4 2013 | $0 | -100.0% | 19 | -99.6% | 0.00% | – |
Q3 2013 | $218,000 | +53.5% | 4,819 | -19.0% | 0.00% | – |
Q2 2013 | $142,000 | – | 5,951 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |